We have demonstrated previously the involvement of certain glycosphingolipids (GSLs) in 'contact inhibition' (dependent on cell-to-cell contact) of cell growth. Here, we examined the roles of specific GSLs in contact inhibition of the human epithelial cell line MCF10A. Contact-inhibited cells show increased expression of the ganglioside GD3 and the globo-series GSL Gb3, and of the mRNAs for the corresponding sialyltransferases ST8SIA1 (GD3 synthase) and galactosyltransferase A4GALT (Gb3 synthase). siRNA knockdown (KD) of ST8SIA1 and/or A4GALT significantly suppresses contact inhibition. Exogenous addition of GD3 or Gb3 inhibits proliferation of lowdensity cells. Our findings suggest that GSLs play functional roles in contact inhibition of these cells and that Merlin/NF2, a tumor suppressor protein, is involved in the GSL function.
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Carbohydrates expressed as glycosphingolipids (GSLs) or glycoproteins are associated with mammalian cell phenotypes and involved in many cellular functions including cell growth, motility, and adhesion. GSLs are expressed mainly on plasma membranes. They were characterized initially as cell surface antigens and shown in subsequent extensive studies by many groups to function as blood group antigens, cell type-specific antigens, stage-specific embryonic antigens, tumor-associated antigens, receptors for microbial toxins such as cholera toxin and verotoxin, mediators of cell adhesion and recognition, and modulators of cell signal transduction [1] [2] [3] [4] . In multicellular organisms, cell growth in various organs is strictly controlled during development to ensure proper relative sizes of the organs. Regulation of cell growth and organ size is also essential for tissue homeostasis in adults. The Hippo signaling pathway is a key pathway in control of organ size of Drosophila melanogaster, and approximately 12 member proteins and multiple downstream effector molecules in this pathway have been characterized [5] . The Hippo pathway is evolutionarily conserved, and its disruption in mammals appears to be associated with tumorigenesis [6, 7] . A core component of the pathway in D. melanogaster is Hippo kinase, an Ste20 family Ser/Thr kinase, whose human homolog is MST1/2. Merlin was identified as an upstream regulator of the pathway and characterized as a protein containing a domain termed FERM (band 4.1, ezrin, radixin, moesin). The human homolog of Merlin is tumor suppressor Merlin/NF2, which is responsible for neurofibromatosis type 2 [8, 9] .
A fundamental property of normal cells in in vitro culture is that proliferation and motility cease when cells come into contact, a phenomenon termed contact inhibition [10] . Oncogenically transformed cells do not display contact inhibition [11] , and loss of this phenomenon is a widely used criterion for cell transformation in vitro [12] . Sialic acids expressed on cell surface Abbreviations EGF(R), epidermal growth factor (receptor); GSL(s), glycosphingolipid(s); KD, knockdown; Merlin, Merlin/NF2. as sialoglyconjugates are apparently involved in contact inhibition [13, 14] . Alteration of ganglioside (sialic acidexpressing GSL) expression, which is often observed during oncogenic transformation, was closely associated with loss of contact inhibition in baby hamster kidney (BHK) cells and hamster fibroblast NIL cells [15] [16] [17] [18] [19] . In a study of human diploid embryonic lung fibroblast WI38 cells [20] , we observed reduction of fibroblast growth factor (FGF)-induced MAPK activation when cells reached confluence and cell growth was inhibited. Ganglioside GM3, the major GSL component of these cells, is associated with FGF receptor and tetraspanins CD9 and CD81 in glycosynaptic microdomains [21] . This study was focused on possible involvement of GSLs in contact inhibition of nontransformed human mammary MCF10A cells. Our findings indicate that ganglioside GD3 and globo-series GSL Gb3, whose expression is upregulated in contact-inhibited cells, play functional roles in maintenance of contact inhibition and suggest that the GSLs function through modulating Merlin/NF2 (Merlin).
Materials and methods

Cell line and cell culture
Immortalized, nontransformed human mammary epithelial cell line MCF10A was purchased from American Type Culture Collection (ATCC; Manassas, VA) and cultured in mammary epithelial cell basal medium (MEBM) (Lonza; Portsmouth, NH) supplemented with MEGM BulletKit (Lonza) components (with the exception of GA-1000), 0. 
Western blot analysis
SDS/PAGE and western blotting were performed as described previously [21, 22, 28] . In brief, cells were harvested and lysed in RIPA buffer: 1% Triton X-100, 150 mM NaCl, 25 mM Tris (pH 7.4), 5 mM EDTA, 0.5% sodium deoxycholate, 0.1% SDS, 5 mM pyrophosphate, 50 mM NaF, 1 mM Na 3 VO 4 , 0.076 unitÁmL À1 aprotinin, 2 mM phenylmethanesulfonyl fluoride (PMSF), and 1% Halt Protease and Phosphatase Inhibitors (Thermo Fisher). Protein concentration was determined using Micro BCA kit (Thermo Fisher), and 10 lg protein in SDS/PAGE sample buffer containing dithiothreitol (DTT) was analyzed using Novex 4-20% Tris-Glycine gels. Proteins were transferred to PVDF membranes (Thermo Fisher), incubated with primary antibodies, and then with appropriate HRP-conjugated secondary antibodies. Signals were revealed using a chemiluminescence detection kit (SuperSignal West Pico; Thermo Fisher). Each membrane was reblotted with anti-GAPDH as loading control after stripping. Signals were detected using a FluorChem E System (ProteinSimple; San Jose, CA), and densities were analyzed using the ImageJ program (NIH; Bethesda, MD).
5 9 10 4 cells in 1% BSA/0.1% NaN 3 /PBS were incubated with primary antibodies in 5% goat serum/1% BSA/0.1% NaN 3 /PBS for 1 h on ice, and then with appropriate Alexa Fluor 488-conjugated secondary antibodies for 30 min on ice. Cells were analyzed using a Sony SH800 flow cytometer and FlowJo software program.
GSL extraction and analysis
GSLs were prepared and analyzed as described previously [22, 28, 30] . In brief, cells were extracted twice by sonication for 30 min in~109 cell pellet volume of isopropanol/hexane/ water (55 : 25 : 20, v/v/v; lower (organic) phase). Combined extracts were evaporated and separated through Folch partition, repeated three times. Upper (aqueous) phases were combined. The lower (organic) phase portion was treated with 0.1 M NaOH to remove phospholipids, as described previously [30] . Each GSL extract was desalted using a Sep-Pak C18 cartridge (Varian; Palo Alto, CA) [30] , and GSLs were analyzed as described previously [22, 30, 31] . GSLs were separated on high-performance TLC (HPTLC) plates (EMD Biosciences; Billerica, MA) using chloroform/methanol/0.5% aqueous CaCl 2 (50 : 40 : 10, v/v/v), and visualized with 0.5% orcinol/sulfuric acid. GSLs in HPTLC plates were also characterized by immunostaining with mAbs after fixing the plates with poly(isobutyl methacrylate). Samples were incubated with appropriate HRP-conjugated secondary antibodies, and signals were detected using a chemiluminescence detection kit (SuperSignal West Dura; Thermo Fisher).
RNA extraction and real-time RT-PCR
Total RNA was extracted and purified using an RNeasy Mini-Prep Kit (Qiagen; Germantown, MD). The first strand of cDNA was prepared from 2 lg RNA using SuperScript III First-Strand Synthesis Super Mix (Invitrogen) with random primers, as per the manufacturer's protocol. Real-time RT-PCR was performed using a StepOnePlus system (Applied Biosystems) as per the manufacturer's instructions; 200 ng of cDNA was used, and relative quantities of mRNAs were determined by the comparative threshold number (Ct value) method. To ensure the reliability of analytical results, cDNA amounts were optimized, Ct values were kept below 35, and GAPDH was used as reference gene. 
Knockdown of ST8SIA1 and A4GALT genes
Exogenous addition of GSLs
Cells were seeded at 1 9 10 4 /cm 2 and cultured for 12 h.
Medium was then replaced by medium containing 100 lM GD3, Gb3, or GD2, and culture was continued 12 h more. BrdU labeling reagent was then added, and culture was continued 24 h more in the presence of the GSLs. Cell proliferation was assayed on the basis of BrdU incorporation. Cells were cultured in medium containing 100 lM GD3, Gb3, or GD2 for 36 h, and then analyzed for GSL expression by cell staining, and for EGFR and MAPK activation levels and phospho-Merlin expression by western blotting.
Statistical analysis
Data were analyzed by t-test using the GraphPad Prism 5 software program. Differences between means with P ≤ 0.05 were considered significant.
Results and Discussion
MCF10A cells show contact inhibition of cell growth
MCF10A, an immortalized but nontransformed human mammary epithelial cell line, displays numerous features of normal breast epithelial cells, including contact inhibition of cell growth [32] . In this study, contact inhibition was confirmed by cell number counting (Fig. 1A) and BrdU uptake [33] (Fig. 1B) . Based on the result, we analyzed and compared lowdensity (sparse-growing) cells (seeded at 1 9 10 4 /cm 2 , cultured for 2 days) and high-density cells (confluent monolayer; contact-inhibited) (seeded at 2 9 10 5 /cm 2 , cultured for 5 days). In the comparison of EGFR and MAPK (p44/42) activation levels, high-density cells showed striking reductions of EGFR activation (assessed by Tyr1068 phosphorylation) and of MAPK activation (assessed by Thr202/Thy204 phosphorylation).
The tumor suppressor Merlin is involved in cell density-dependent growth inhibition [34, 35] . Mutations or reduced expression of Merlin are associated with tumorigenesis and have been reported in various tumors [36, 37] . Merlin is phosphorylated at Ser and Thr residues, and phosphorylation at Ser518 inhibits Merlin's ability to suppress cell growth [38] [39] [40] [41] . Consistent with these previous findings, we observed that Ser518 phosphorylation of Merlin was significantly lower in high-density cells (Fig. 1C ).
GD3 and Gb3 expression is enhanced in high-density cells
GSL expression profiles were compared by flow cytometry. GD3 and Gb3 expression were observed in (respectively) 79% and 97% of high-density cells, but only 13% and 36% of low-density cells (Fig. 2A) . No notable difference in expression of GD2 was observed. Slightly enhanced expression of Globo-H, SSEA3, and SSEA4 was observed in high-density cells. We focused on GD3 and Gb3, whose expression was strikingly enhanced in high-density cells (Fig. 2A) . GSLs were extracted from high-and low-density cells, separated by Folch partition into polar upper (aqueous) phase and nonpolar lower (organic) phase, and analyzed by HPTLC immunostaining. Phospholipids in the lower (organic) phase were removed by alkaline treatment as described previously [30] . GSLs in both phases were developed on HPTLC plates and stained with orcinol/sulfuric acid or detected by immunostaining with specific antibodies. Orcinol staining revealed slightly different GSL expression patterns in high-vs. low-density cells, and immunostaining showed higher GD3 and Gb3 expression in high-density cells (Fig. 2B) . Gb3 was only weakly detected in upper (aqueous) phase. Analysis of lower-phase fractions showed clear enhancement of Gb3 expression in highdensity cells (Fig. 2C ). GD2 expression levels were similar in high-and low-density cells (Fig. 2B ). GM3 expression in both upper and lower (organic) phase was significantly reduced in high-density cells (Fig. 2B,C) . It is unlikely that cell growth inhibition resulted from GM3 downregulation, in view of our finding (see below) that exogenous addition of GD3 or Gb3 to lowdensity cells inhibited cell growth. and Merlin was analyzed by western blotting as described in M&M, and compared between low-and high-density cells. GAPDH was determined as load control after stripping. GAPDH(p): membrane analyzed for phosphorylated proteins; GAPDH: membrane analyzed for nonphosphorylated proteins. Values shown are mean AE SD (n = 3). **P < 0.01; ***P < 0.001. In view of the differential expression of GSLs in highvs. low-density cells, we used real-time RT-PCR to compare expression levels of mRNAs for glycosyltransferases involved in synthesis of ganglio-and globo-series GSLs (Fig. 3A) . Levels of ST8SIA1 (GD3 synthase) and A4GALT (Gb3 synthase) were, respectively, 8.7-fold and 21.6-fold higher in high-density cells, consistent with the enhanced expression of GD3 and Gb3 in these cells. The level of B4GALNT1 (GM2/GD2 synthase) was only slightly (0.6-fold) lower in high-density cells, consistent with the similar amounts of GD2 in high-and low-density cells. mRNA level of ST3GAL5 (GM3 synthase) was~3-fold higher in high-density cells, even though the amount of GM3 detected in these cells by HPTLC immunostaining with specific mAb DH2 was much lower. This apparent inconsistency between GM3 amount and ST3GAL5 mRNA level can be explained by the relatively much greater increase of ST8SIA1 mRNA than of ST3GAL5 mRNA in these cells (Fig. 3B) , i.e. although more GM3 is synthesized in high-density cells, much more GM3 is converted to GD3 (Fig. 3A) .
Expression levels of certain GSLs are notably altered in contact-inhibited cells. Some examples are enhanced expression of Gb3 in BHK cells, of GD3 and GM1 in human fibroblast cells [15] , and of Gb5 and GM3 in hamster NIL cells [16, 17, 19] . Such enhanced expression of specific GSLs, as well as contact inhibitability, are lost following oncogenic transformation. The present findings in MCF10A cells indicate involvement of GSLs in contact inhibition, consistent with many previous studies of other cell types. Whether oncogenic transformation of MCF10A cells results in altered GSL expression along with the loss of contact inhibition remains to be studied. 
Contact inhibition is suppressed by ST8SIA1 and/or A4GALT knockdown
In view of the enhanced expression of GD3 and Gb3 (and their synthases) in high-density cells, we investigated the functional roles of these GSLs in contact inhibition. ST8SIA1 and A4GALT were knocked down using the siRNA approach, and three types of knockdown (KD) cells were prepared: KD-ST8SIA1, KD-A4GALT, and KD-ST8SIA1/A4GALT (double knockdown). Control cells were transfected with control siRNA. Effects of such KD on mRNA levels 24 h after transfection were evaluated by real-time RT-PCR. Relative to controls, mRNA levels were reduced~70% and~53% in KD-ST8SIA1 and KD-A4GALT cells for the respective synthases and reduced~74% for both synthases in KD-ST8SIAI/ A4GALT (Fig. 4A) . Transfected cells were seeded at 2 9 10 5 /cm 2 , cultured for 4 days to achieve confluency (high density), and GD3 and Gb3 expression were evaluated by cell staining/flow cytometry. The percentage of GD3-positive cells was 11.5% in KD-ST8SIA1, 9.0% in KD-ST8SIA1/A4GALT, and much higher (58.3%) in controls. Mean fluorescent intensity (MFI) was reduced 80% in both KD-ST8SIA1 and KD-ST8SIA1/ A4GALT. The percentage of Gb3-positive cells was 25.9% in KD-A4GALT, 27.3% in KD-ST8SIA1/ A4GALT, and much higher (61.4%) in controls. MFI was reduced~45% in both KD-A4GALT and KD-ST8SIA1/A4GALT (Fig. 4B) . For proliferation analysis, transfected cells were seeded at 2 9 10 5 /cm 2 , cultured for 3 days, added with BrdU labeling reagent, and cultured for another 24 h. The percentage of BrdU-positive cells was~21% in KD-ST8SIA1, 25% in KD-A4GALT, 22% in KD-ST8SIA1/A4GALT, and only 5% in controls (Fig. 4C) . The above findings, taken together, indicate the functional involvement of GD3 and Gb3 in contact inhibition of MCF10A cell growth. No synergetic effect of the KD of ST8SIA1 and A4GALT was observed in KD-ST8SIA1/A4GALT, suggesting that GD3 and Gb3 may exert their contact-inhibitory effects through similar mechanisms. Consistent with increased DNA synthesis, activation of EGFR and of MAPK was significantly enhanced in the three KD cell lines. Expression levels of phospho-Merlin (Ser518) were also significantly higher in the KD cells than in controls (Fig. 4D) .
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Exogenous addition of GD3 or Gb3 inhibits growth of low-density cells
In view of the above findings, we examined the effects of exogenously added GD3 or Gb3 on growth of lowdensity cells. GD2 was used as negative control. In our preliminary experiments to compare effects of GSL concentrations, the growth-inhibitory effects of 100 lM GD3 and Gb3 were slightly higher than those of 50 lM concentration, while GD2 had no nonspecific effect at concentrations up to 100 lM. We, therefore, used a concentration of 100 lM in subsequent experiments. When cells were cultured for 36 h with 100 lM GD3, Gb3, or GD2, surface expression of the ganglioside was greatly increased, as expected (Fig. 5A) . Flow cytometric analysis showed 99% GD3 positivity in GD3-treated cells, 99% GD2 positivity in GD2-treated cells, and 76% Gb3 positivity in Gb3-treated cells.
For proliferation assay, treated cells were cultured with BrdU labeling reagent during the final 24 h. BrdU positivity was 81% in cells cultured without exogenous GSL addition and much lower in GD3-treated (55%) and Gb3-treated cells (62%). In contrast, BrdU positivity was 77% in GD2-treated cells (Fig. 5B) , indicating that the inhibitory effects of GD3 and Gb3 do not reflect nonspecific GSL activity. Upregulation of GD3 and Gb3, rather than downregulation of GM3 (Fig. 2B,C) , evidently plays an important role in growth inhibition of these cells. Relative to non-GSL-added control cells, activation of EGFR and of MAPK was notably reduced in GD3-and Gb3-treated cells, but not significantly different in GD2-treated cells (Fig. 5C ). Merlin was hypo-phosphorylated in GD3-and Gb3-treated cells, whereas Merlin phosphorylation level in GD2-treated cells was similar to that in non-GSL-added controls.
Inhibitory effects of various gangliosides on EGFR have been extensively studied. GM3 and its derivatives are strong inhibitors of EGFR activation [42] [43] [44] [45] . GD3 had no detectable inhibitory effect on EGFR activation in human A431 cells [44] ; it is, therefore, unlikely that GD3 binds EGFR on the plasma membrane to inhibit EGF-induced EGFR activation. Our findings that KD of glycosyltransferase ST8SIA1 or A4GALT causes hyper-phosphorylation of Merlin (Fig. 4D) , whereas exogenous GD3 or Gb3 addition results in hypo-phosphorylation of Merlin (Fig. 5C ) indicate that Merlin is involved in GSL inhibitory effects. Merlin is localized mainly on plasma membrane and cytoskeletal compartments and is associated with numerous transmembrane proteins, including EGFR, integrins, and CD44 [46] . Recent studies indicate that Merlin mediates contact inhibition of cell proliferation by inhibiting internalization of EGFR [34, 47] , is resistant to solubilization by detergent Triton X-100 [48] , and is present in GSL-enriched microdomain (GEM), in which GSLs are associated with a variety of signal transducer molecules including Src family kinases and small G-proteins [21, [49] [50] [51] . Taken together, these findings suggest possible interactions between GSLs and Merlin in GEM. Future investigation of this possibility will help clarify the role of GSLs in contact inhibition. Certain types of cell-cell adhesion appear to be based on carbohydrate-to-carbohydrate interaction [52] . An intriguing possibility is that such interactions between the GSLs facilitate Merlin function in contact-inhibited cells.
